Han‐Ming Lu

492 total citations
23 papers, 411 citations indexed

About

Han‐Ming Lu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Han‐Ming Lu has authored 23 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Han‐Ming Lu's work include Liver physiology and pathology (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Berberine and alkaloids research (3 papers). Han‐Ming Lu is often cited by papers focused on Liver physiology and pathology (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Berberine and alkaloids research (3 papers). Han‐Ming Lu collaborates with scholars based in China. Han‐Ming Lu's co-authors include Dingguo Li, Qinfang Xu, Huijuan Zhou, Youxin Jin, Shan Jiang, Xin Huang, Yi Shi, Mingjun Zhang, Qing Xie and Guangming Li and has published in prestigious journals such as Journal of Ethnopharmacology, World Journal of Gastroenterology and The Journal of Gene Medicine.

In The Last Decade

Han‐Ming Lu

22 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han‐Ming Lu China 10 202 164 150 54 48 23 411
Kenichi Okano Japan 11 152 0.8× 126 0.8× 89 0.6× 41 0.8× 58 1.2× 24 341
Maria Ruart Spain 7 189 0.9× 258 1.6× 124 0.8× 39 0.7× 81 1.7× 9 478
Su Suriguga Netherlands 8 194 1.0× 188 1.1× 154 1.0× 48 0.9× 91 1.9× 13 452
Kengo Kawai Japan 11 181 0.9× 342 2.1× 130 0.9× 29 0.5× 87 1.8× 26 584
Giacomo Batignani Italy 2 183 0.9× 233 1.4× 127 0.8× 37 0.7× 77 1.6× 5 357
Mike A. Leonis United States 14 210 1.0× 84 0.5× 157 1.0× 63 1.2× 102 2.1× 19 497
Xiaodan Ren United States 11 204 1.0× 125 0.8× 103 0.7× 38 0.7× 128 2.7× 17 463
G. Della Libera Italy 8 203 1.0× 228 1.4× 100 0.7× 43 0.8× 138 2.9× 10 527
Beatriz Barranco-Fragoso Mexico 8 228 1.1× 327 2.0× 66 0.4× 34 0.6× 59 1.2× 13 432
Mitsuru Ohata Japan 9 151 0.7× 241 1.5× 125 0.8× 25 0.5× 54 1.1× 20 451

Countries citing papers authored by Han‐Ming Lu

Since Specialization
Citations

This map shows the geographic impact of Han‐Ming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Ming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Ming Lu more than expected).

Fields of papers citing papers by Han‐Ming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Ming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Ming Lu. The network helps show where Han‐Ming Lu may publish in the future.

Co-authorship network of co-authors of Han‐Ming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Ming Lu. A scholar is included among the top collaborators of Han‐Ming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Ming Lu. Han‐Ming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenxi, Yingwei Chen, Yuqin Wang, et al.. (2012). Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis. Medical Science Monitor. 18(10). BR394–BR401. 9 indexed citations
2.
Sun, Chao, et al.. (2008). Transplantation of urokinase‐type plasminogen activator gene‐modified bone marrow‐derived liver stem cells reduces liver fibrosis in rats. The Journal of Gene Medicine. 10(8). 855–866. 13 indexed citations
3.
Li, Dingguo, Qing Xie, Yi Shi, et al.. (2008). [Effect of silencing connective tissue growth factor on rat liver fibrosis and the accumulation of extracellular matrix].. PubMed. 16(3). 188–92. 4 indexed citations
4.
Li, Dingguo, et al.. (2008). [Risk factors of irritable bowel syndrome in adolescents in China].. PubMed. 46(2). 136–8. 3 indexed citations
5.
Hu, Yingbin, et al.. (2007). Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase‐2 inhibits hepatic fibrogenesis in rats. The Journal of Gene Medicine. 9(3). 217–229. 36 indexed citations
6.
Li, Dingguo, et al.. (2007). [An epidemiologic study of irritable bowel syndrome among adolescents in China].. PubMed. 46(2). 99–102. 7 indexed citations
7.
Li, Dingguo, et al.. (2007). [An epidemiologic study of functional bowel disorders in adolescents in China].. PubMed. 87(10). 657–60. 2 indexed citations
8.
Li, Guangming, Qing Xie, Yi Shi, et al.. (2006). Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. The Journal of Gene Medicine. 8(7). 889–900. 137 indexed citations
9.
Chen, Yuanwen, et al.. (2005). Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-β in vitro via up-regulation of Smad 7. Journal of Ethnopharmacology. 100(3). 299–305. 24 indexed citations
10.
Pan, Qin, et al.. (2004). Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World Journal of Gastroenterology. 10(7). 1015–1015. 10 indexed citations
11.
Pan, Qin, et al.. (2004). Relationship between somatostatin receptors and activation of hepatic stellate cells.. PubMed. 117(11). 1665–9. 6 indexed citations
12.
Zhou, Xin, Dingguo Li, Xuanhai Li, Han‐Ming Lu, & Wenzhu Zhang. (2003). A combination of Ang II and carbon tetrachloride accelerates process of hepatic fibrosis.. PubMed. 116(1). 62–5. 1 indexed citations
13.
Wu, Jianxin, et al.. (2002). [Factors related to acute upper gastrointestinal bleeding after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].. PubMed. 21(8). 881–4. 3 indexed citations
14.
Huang, Xin, Dingguo Li, Han‐Ming Lu, et al.. (2002). [Expression of activins, follistatin mRNA in the development of hepatic fibrosis].. PubMed. 10(2). 85–8. 5 indexed citations
15.
Li, Dingguo, Zhirong Wang, & Han‐Ming Lu. (2001). Pharmacology of tetrandrine and its therapeutic use in digestive diseases. World Journal of Gastroenterology. 7(5). 627–627. 16 indexed citations
16.
Li, Dingguo, Zhirong Wang, & Han‐Ming Lu. (2001). Pharmacology of tetrandrine and its therapeutic use in digestive diseases. World Journal of Gastroenterology. 7(5). 627–627. 1 indexed citations
17.
Lu, Han‐Ming, et al.. (2001). The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.. PubMed. 114(6). 583–7. 12 indexed citations
18.
Li, Dingguo, Hongshan Wei, Zhirong Wang, et al.. (2000). Emodin on hepatic fibrosis in rats.. PubMed. 113(7). 599–601. 36 indexed citations
19.
Liu, Xuesong, et al.. (1997). Effects of tetrandrine and verapamil on fibroblastic growth and proliferation.. PubMed. 3(2). 68–68. 5 indexed citations
20.
Liu, Hailin, et al.. (1995). Effects of tetrandrine and chlorpromazine on synthesis of collagen and hyaluronic acid in cultured human lung fibroblasts.. PubMed. 16(5). 412–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026